Banville Law

LegalHerald.com reports on a verdict that was handed down last November for a lawsuit filed under case number 130401990. (read more...)

LegalHerald.com reports on the fourth Risperdal lawsuit to go to trial which has resulted in a ruling in favor of the plaintiff. (read more...)

LegalHerald.com reports on the verdicts of two Risperdal lawsuits which resulted in plaintiffs being awarded millions. (read more...)

LegalHerald.com comments on details surrounding current Risperdal-related trials filed against defendant Johnson & Johnson. (read more...)

LegalHerald.com reports on the U.S. (read more...)

LegalHerald.com reports on a lawsuit verdict from last November in a case filed under number 130401990 which discussed antipsychotic drug Risperdal. (read more...)

LegalHerald.com comments on recent reports indicating that the U.S. (read more...)

LegalHerald.com reports on an $8 million dollar reward received by the family of a man who died during a Risperdal clinical trial. (read more...)

LegalHerald.com reports on a decision by the United States Supreme Court that they will not hear pharmaceutical giant Johnson & Johnson’s appeal of a $124 million judgement that has been made agai. (read more...)

LegalHerald.com comments on reports stating that of four trials referencing Risperdal, which took place last year, three have been won by plaintiffs. (read more...)

LegalHerald.com reports on another Risperdal lawsuit filed in the U.S. (read more...)

LegalHerald.com comments on reports that Johnson & Johnson has been ordered to pay millions of dollars in compensation in Risperdal jury verdicts. (read more...)

LegalHerald.com reports on another lawsuit which has been filed regarding the anti-psychotic drug Risperdal. (read more...)

LegalHerald.com reports on a lawsuit which was filed in December of 2014 by a mother on behalf of her 17-year old son regarding the anti-psychotic drug Risperdal. (read more...)

LegalHerald.com reports on the results of a Risperdal-related lawsuit filed against manufacturer Janssen Pharmaceuticals (a division of Johnson & Johnson corporation). (read more...)

LegalHerald.com comments on recent reports that controversial testimony from a Johnson & Johnson biochemist during a Risperdal lawsuit trial indicated that the corporate giant had intentionally co. (read more...)

LegalHerald.com reports on a lawsuit which was filed in reference to antipsychotic drug Risperdal. (read more...)

LegalHerald.com reports on the third trial loss suffered by Johnson & Johnson subsidiary Janssen Pharmaceuticals when a Philadlphia jury decided on a verdict against them concerning a lawsuit surr. (read more...)

LegalHerald.com reports on the verdicts of three Risperdal lawsuits in which the plaintiffs alleged to have suffered from gynecomastia (male breast growth) as a result of their use of the antipsychoti. (read more...)

LegalHerald.com reports on the results of a clinical study which support the claims of several Risperdal lawsuit plaintiffs who allege that use of the drug caused them to develop gynecomastia. Risper. (read more...)

LegalHerald.com comments on reports that a Philadlphia jury gave pharmaceutical giant Johnson & Johnson their third trial loss concerning the antipsychotic drug, Risperdal, which they manufacture . (read more...)

LegalHerald.com reports on a lawsuit filed on November 21, 2014, in Jefferson County District Court under case number A-196444 by a Texas man. (read more...)

LegalHerald.com reports on recent news that testimony from a Johnson & Johnson biochemist during trial showed that the pharmaceutical giant had hidden certain study results connecting its antipsyc. (read more...)

LegalHerald.com reports on the conclusion of a lawsuit filed against Johnson & Johnson subsidiary Jasnssen Pharmaceuticals regarding the anti-psychotic drug they manufacture, Risperdal. (read more...)

LegalHerald.com reports on the outcomes of four Risperdal lawsuits which all similarly allege that use of the antipsychotic caused gynecomastia (male breast growth) in the plaintiffs. (read more...)